Cullen Frost Bankers Inc. Sells 5,929 Shares of The Clorox Company $CLX

Cullen Frost Bankers Inc. decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 10.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,597 shares of the company’s stock after selling 5,929 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Clorox were worth $4,900,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLX. State Street Corp increased its holdings in shares of Clorox by 3.5% in the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after purchasing an additional 282,794 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Clorox by 23.1% during the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock worth $492,656,000 after buying an additional 750,415 shares during the last quarter. Van ECK Associates Corp boosted its holdings in shares of Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after buying an additional 1,312,471 shares during the period. Two Sigma Investments LP boosted its holdings in shares of Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares during the period. Finally, Northern Trust Corp grew its stake in Clorox by 4.8% in the 3rd quarter. Northern Trust Corp now owns 1,539,006 shares of the company’s stock valued at $189,759,000 after buying an additional 70,783 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.63% of the stock is owned by corporate insiders.

Clorox Stock Performance

NYSE CLX opened at $95.18 on Friday. The firm has a 50-day moving average price of $100.33 and a two-hundred day moving average price of $106.37. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03. The company has a market capitalization of $11.51 billion, a P/E ratio of 15.45, a P/E/G ratio of 0.49 and a beta of 0.59. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the firm earned $1.45 earnings per share. The business’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd were issued a $1.24 dividend. The ex-dividend date of this dividend was Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 5.2%. Clorox’s payout ratio is currently 80.52%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. Royal Bank Of Canada decreased their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Jefferies Financial Group lowered their target price on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Finally, TD Cowen boosted their price target on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.